Maria Learoyd
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
- Oncology 10
- PARP inhibition in cancer therapy 9
-
- Antibiotic Resistance in Bacteria 3
- Co-authors
- Timi I. Edeki (5 shared papers)Shampa Das (3 shared papers)Jon M. Armstrong (2 shared papers)James Li (2 shared papers)Carsten Dietrich Goessl (2 shared papers)Joseph E. Burgents (1 shared paper)Vincenzo Emanuele Chiurì (1 shared paper)Charles H. Redfern (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (3 papers)Clinical Pharmacokinetics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)British Journal of Clinical Pharmacology (1 paper)Advances in Therapy (1 paper)
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Maria Learoyd
23 papers receiving 1.2k citations
Maria Learoyd's Hit Papers
Peers
Comparison fields: 5 of 78
- Molecular Medicine 150
- Oncology 538
- Applied Microbiology and Biotechnology 34
- Pulmonary and Respiratory Medicine 301
- Reproductive Medicine 77
Countries citing papers authored by Maria Learoyd
This map shows the geographic impact of Maria Learoyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Learoyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Learoyd more than expected).
Fields of papers citing papers by Maria Learoyd
This network shows the impact of papers produced by Maria Learoyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Learoyd. The network helps show where Maria Learoyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Maria Learoyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial Hit paper breakdown → | 2018 | 324 |
| 2 | 2014 | 128 | |
| 3 | 2011 | 120 | |
| 4 | 2015 | 117 | |
| 5 | 2018 | 117 | |
| 6 | 2018 | 53 | |
| 7 | 2013 | 43 | |
| 8 | 2011 | 40 | |
| 9 | 2015 | 39 | |
| 10 | 2015 | 33 | |
| 11 | 2017 | 30 | |
| 12 | 2019 | 27 | |
| 13 | 2018 | 26 | |
| 14 | 2013 | 22 | |
| 15 | 2018 | 19 | |
| 16 | 2015 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2018 | 12 | |
| 19 | 2019 | 8 | |
| 20 | 2015 | 3 |
About Maria Learoyd
Maria Learoyd is a scholar working on Oncology, Molecular Medicine, Pharmacology, Neurology and Molecular Biology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Melanoma and MAPK Pathways (2 papers), Pneumonia and Respiratory Infections (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Neurofibromatosis and Schwannoma Cases (2 papers). The work is most often cited by research in Molecular Medicine (150 citations), Oncology (538 citations), Applied Microbiology and Biotechnology (34 citations), Pulmonary and Respiratory Medicine (301 citations) and Reproductive Medicine (77 citations). Maria Learoyd has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Timi I. Edeki, Shampa Das, Jon M. Armstrong, James Li, Carsten Dietrich Goessl, Joseph E. Burgents, Vincenzo Emanuele Chiurì, Charles H. Redfern, Jacek Jassem and Robert Kozarski. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics, Cancer Chemotherapy and Pharmacology, British Journal of Clinical Pharmacology and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.